Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties.
Marín L, Miguélez EM, Villar CJ, Lombó F. · 2015
Read Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. by Marín L, Miguélez EM, Villar CJ, Lombó F. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4352739.txt.
Introduction
Laura Marín, Elisa Miguélez, Claudio Villar, and Felipe Lombó reviewed plant polyphenols in BioMed Research International in 2015. Polyphenols are a large, varied family of plant compounds found in foods, including flavonoids, tannins, and chlorogenic acids. Their review asks how much of these compounds the body can use, how gut microbes change them, and whether the changed forms can kill germs.
Most polyphenols reach the gut tied to sugars, so enzymes and gut microbes must first trim them before they can be absorbed into the blood. From there they pass to the liver and other organs, or leave in urine. Along that path, the compounds and their breakdown products show strong action against viruses, bacteria, and parasites. Which microbes do the trimming shapes which active forms appear.
Catalog record
| CREATOR | Marín L, Miguélez EM, Villar CJ, Lombó F. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties By Laura Marín, Elisa M. Miguélez, Claudio J. Villar, Felipe Lombó Published in: BioMed Research International DOI: 10.1155/2015/905215 ABSTRACT Polyphenolic compounds are plant nutraceuticals showing a huge structural diversity, including chlorogenic acids, hydrolyzable tannins, and flavonoids (flavonols, flavanones, flavan-3-ols, anthocyanidins, isoflavones, and flavones). Most of them occur as glycosylated derivatives in plants and foods. In order to become bioactive at human body, these polyphenols must undergo diverse intestinal transformations, due to the action of digestive enzymes, but also by the action of microbiota metabolism. After elimination of sugar tailoring (generating the corresponding aglycons) and diverse hydroxyl moieties, as well as further backbone reorganizations, the final absorbed compounds enter the portal vein circulation towards liver (where other enzymatic transformations take place) and from there to other organs, including behind the digestive tract or via blood towards urine excretion. During this transit along diverse tissues and organs, they are able to carry out strong antiviral, antibacterial, and antiparasitic activities. This paper revises and discusses these antimicrobial activities of dietary polyphenols and their relevance for human health, shedding light on the importance of polyphenols structure recognition by specific enzymes produced by intestinal microbial taxa. 1. BIOAVAILABILITY OF DIETARY POLYPHENOLS 1.1. Structural Diversity Flavonoids are very abundant 15C secondary metabolites in plants, containing two aromatic rings (connected by a heterocycle pyrone ring), which are tailored with diverse hydroxyl moieties. Some are produced at chloroplasts as defense against oxidative damage generated during photosynthesis [1]; others are produced at the sexual organs as defense against solar UV [2], at the root area as attractants for bacterial and fungal symbionts [3], or as defense against virus, bacteria, fungi, and herbivores [4]. All flavonoids derive from L-phenylalanine, due to diverse transformations taking place at the phenylpropanoid pathway. Initial common steps are conversion of L-Phe in cinnamic acid (by phenyl ammonia lyase (PAL)), its conversion in p-coumaric acid (by cinnamate-4-hydroxylase (C4H)), and its transformation in p-coumaroyl-CoA (by 4-coumaroyl-CoA ligase (4CL)) [5]. Both p-coumaric acid and p-coumaroyl-CoA are building blocks for hydroxycinnamic acids and flavonoids, respectively (Figure 1) [5]. In flavonoid biosynthesis, one molecule of p-coumaroyl-CoA and three molecules of malonyl-CoA are used by the chalcone synthase (CHS) in order to generate a bicyclic chalcone as naringenin chalcone (Figure 1) [4]. Chalcones are substrates for chalcone isomerase (CHI), which carries out the B-ring closure at these compounds, rendering flavanones (as naringenin from citrus fruits) (Figure 2). All flavonoid subfamilies derive from these 15C flavanones (Figure 2 shows the atom numbering and ring denomination). Other phenylpropanoid enzymes will generate diverse final products as shown in Figure 2 [4]. Flavone synthase (FNS) will generate flavones (as apigenin from celery). Isoflavone synthase (IFS) will generate isoflavones (as genistein from soy). Flavanone-3-hydroxylase (F3H) will generate dihydroflavonols (as aromadendrin from pine trees). Flavonol synthase (FLS) will generate flavonols (as quercetin from onion or kaempferol from capers). Dihydroflavonol reductase (DFR) and anthocyanin synthase (ANS) will generate anthocyanidins (as pelargonidin from diverse red flowers). Anthocyanidin reductase (ANR) will generate flavan-3-ols (as epicatechin from cocoa). Flavonoids are usually present and stored in plant tissues in the form of diverse derivatives, mostly as sugar O-conjugates at C2 (chalcones), at C3 (flavonols, anthocyanidins, and flavan-3-ols), or at C7 (flavanones, flavones, and isoflavones) positions. Most common bound sugars are glucose, galactose, rhamnose, xylose, rutinose, arabinopyranose, and arabinofuranose [6]. These modifications (and others as methylations and gallate tailoring) add extra structural stability to flavonoids during storage in vacuoles and chloroplasts [7–9]. Once the plant, fruit, or seed is recollected, flavonoids usually have good stability in this conjugated state and keep high concentrations in food and beverages. All these modifications in chemical structure and sugar binding will determine their absorption and bioavailability [10–13]. 1.2. Intestinal Absorption The study of flavonoids metabolism in human body is crucial to determine which ones are better absorbed and which ones lead to formation of bioactive metabolites. Following the ingestion of flavonoids, sugar moieties (as in quercetin-3-glucoside) are cleaved from the phenolic backbone in the small intestine and absorbed here. Enzymes as lactase phlorizin hydrolase (LPH) (at enterocyte membrane) or β-glucosidase (CBG) (cytosolic, for polar glycosides) hydrolyze glycosylated flavonoids and then aglycones enter epithelial cells by passive diffusion [14–16] (Figure 3). However, flavonoids linked to a rhamnose moiety must reach the colon and be hydrolyzed by the α-rhamnosidases secreted by the colon microbiota (as Bifidobacterium dentium), in order to proceed to its absorption [17] (Figure 3). Flavan-3-ols, such as (−)-epicatechin, are never glycosylated but often acylated by gallic acid. These compounds are absorbed at enterocyte level without any deconjugation or hydrolysis [18]. Proanthocyanidins are polymers of high molecular weight, and therefore oligomers larger than trimers are unlikely to be absorbed in the small intestine in their native form [19]. The other main family of polyphenols, hydroxycinnamic acids, are commonly esterified to sugars, organic acids, and lipids. There are no esterases in human tissues able to break these ester links, so the main site for its metabolism is colonic microbiota, although up to one third of their absorption can also take place in the small intestine [46–49]. Some hydroxycinnamic acids, as ellagitannins, are polymers (Figure 4). These are resistant to the action of LPH or CBG and consequently cannot be absorbed in the small intestine, reaching the colon, where its microbiota cleaves the conjugating moieties. The resultant aglycones are extensively metabolized by this microbiota, leading to the production of various hydroxyphenylacetic acids [50, 51]. Once a final derivative or aglycon has been absorbed (at small intestine or colon), it undergoes some degree of phase II metabolism at enterocyte level, as methylation (at C3′ or C4′ by catechol-O-methyltransferase (COMT)), sulfation (at C3′, C4′, C5, or C7 by sulfotransferases (SULT)), and glucuronidation (by UDP-glucuronosyltransferases) (Figure 3). Then these products enter the blood stream by the portal vein, reaching the liver, where they may be subjected to more phase II metabolism, hence becoming conjugated and transported to the bloodstream again until they are secreted in urine (Figure 3) [25, 52–61]. Some of the liver conjugates are then excreted as bile components back into the intestine (enterohepatic recirculation) and deconjugated compounds are regenerated by gut microbial enzymes before being reabsorbed again [21, 62, 63]. The unabsorbed metabolites are eliminated via faeces (Figure 3). All these conjugation mechanisms are highly efficient, and free aglycones are generally absent or present in low concentrations in plasma after nutritional doses. An exception is green tea catechins, whose aglycones constitute a significant proportion of the total amount in plasma, as they are nonglycosylated flavonoids in food and are readily absorbed at the small intestine without extra modifications [12]. 2. ANTIMICROBIAL EFFECTS OF DIETARY POLYPHENOLS AND THEIR GUT MICROBIOTA METABOLITES The level of biotransformations suffered by a specific dietary polyphenol along the gastrointestinal tract is determined by two main factors. One is the specific structural subfamily of the polyphenol, as its scaffold will allow only some transformations, to be carried out by intestinal enzymes and gut microbiota species. This chemical structure will therefore, at this initial level, restrict the range of possible final bioactive products to be absorbed and consequently the scale of possible antimicrobial properties generated as a result of these biotransformations on dietary polyphenols. The second factor